Search Within

ACTIVE HEPATITIS

New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets

Journal: Current Drug Targets
Volume: 18, Issue: 8
Page: 908-920
Authors: Alvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, Luis Bujanda, Jesus M. Banales and Maria J. Perugorria*

Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib

Journal: Current Drug Targets
Volume: 17, Issue: 7
Page: 783-799
Authors: Gianluigi Mazzoccoli, Luca Miele, Jude Oben, Antonio Grieco and Manlio Vinciguerra

Recent Advances in Active Hepatic Targeting Drug Delivery System

Journal: Current Drug Targets
Volume: 15, Issue: 6
Page: 573-599
Authors: Yang Wang, Hongliang Du and Guangxi Zhai

Vitamin K2-Enhanced Liver Regeneration is Associated with Oval Cell Expansion and Up-Regulation of Matrilin-2 Expression in 2- AAF/PH Rat Model

Journal: Current Molecular Medicine
Volume: 14, Issue: 3
Page: 361-369
Authors: M. Lin, P. Sun, G. Zhang, X. Xu, G. Liu, H. Miao, Y. Yang, H. Xu, L. Zhang, P. Wu and M. Li

Role of Oxidative Stress and Molecular Changes in Liver Fibrosis: A Review

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 28
Page: 4850-4860
Authors: V. Sanchez-Valle, N. C. Chavez-Tapia, M. Uribe and N. Mendez-Sanchez

Smad3-Mediated Signals Showing Similarities and Differences Between Epithelial and Mesenchymal Cells in Human Chronic Liver Diseases

Journal: Current Enzyme Inhibition
Volume: 6, Issue: 2
Page: 57-66
Authors: Koichi Matsuzaki

The Role of the Nervous System in the Regulation of Liver Cytochrome P450

Journal: Current Drug Metabolism
Volume: 12, Issue: 2
Page: 124-138
Authors: Jacek Wojcikowski and Wladyslawa Anna Daniel

Antifibrogenic Therapies in Chronic HCV Infection

Journal: Current Drug Targets - Infectious Disorders
Volume: 1, Issue: 2
Page: 227-240
Authors: I. shimizu

Renin-Angiotensin System Inhibitors as Therapeutic Alternatives in the Treatment of Chronic Liver Diseases

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 26
Page: 2749-2754
Authors: Hitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, Mitsuteru Kitade, Kosuke Kaji, Tatsuhiro Tsujimoto, Masahito Uemura and Hiroshi Fukui

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

Journal: Current Pharmaceutical Design
Volume: 8, Issue: 11
Page: 977-980
Authors: Antonio Ascione, Massimo De Luca, Giovan Giuseppe Di Costanzo, Francesco aolo Picciotto, Alfonso Galeota Lanza, Carmine Canestrini, Filomena Morisco, Concetta Tuccillo and Nicola Caporaso